Prime Medicine, Inc.
PRME- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001894562
No open-market purchases or sales by Prime Medicine, Inc. insiders were filed in the last 90 days; 187 institutions reported holding it in 13F filings for Q2 2026, worth $393.5M in total; ARK Invest is the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Prime Medicine, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 79 | 1 | 83 | +5 |
| Shares | 46.1M | 500 | 49.5M | +3.39M (+7.3%) |
| Value | $675.7M | $8.00K | $472.3M | −$203.4M (−30.1%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Prime Medicine, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rafferty Asset Management, LLC | 128,876 | $1.23M | 0.01% |
| Two Sigma Investments, LP | 92,993 | $887.2K | 0.00% |
| Goldman Sachs Group Inc | 58,911 | $562.0K | 0.00% |
| Profund Advisors LLC | 21,995 | $209.8K | 0.01% |
| Envestnet Asset Management Inc | 16,616 | $158.5K | 0.00% |
| Squarepoint Ops LLC | 15,490 | $147.8K | 0.00% |
| Virtu Financial LLC | 12,466 | $119.0K | 0.01% |
| Walleye Capital LLC | 10,700 | $102.1K | 0.00% |
| Citadel Advisors LLC | 6,524 | $62.2K | 0.00% |
| Comerica Bank | 779 | $7.43K | 0.00% |
| Grove Bank & Trust | 77 | $735 | 0.00% |
Sold out (6)
Institutions that held Prime Medicine, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Jane Street Group, LLC | 397,004 | $5.82M |
| Millennium Management LLC | 256,560 | $3.76M |
| Laurion Capital Management LP | 55,888 | $818.8K |
| Levin Capital Strategies, L.P. | 20,000 | $293.0K |
| Susquehanna International Group, LLP | 12,254 | $179.5K |
| CWM, LLC | 15 | $0 |
Not filed for Q3 2023 yet (1)
Institutions that held Prime Medicine, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Endurance Wealth Management, Inc. | 500 | $8.00K |